Month: October 2012

SIGN PETITION: Gilead Sciences: Please collaborate with Bristol Myers for the Cure for Hepatitis C NOW!

Gilead Sciences: Please collaborate with Bristol Myers for the Cure for Hepatitis C NOW! The most effective new therapy ever discovered for the treatment of hepatitis C will never see the light of day unless we are able to convince big pharma giant Gilead Sciences to move forward at once with this development. This treatment combines Bristol-Myers Squibb drug daclatasvir and …

SIGN PETITION: Gilead Sciences: Please collaborate with Bristol Myers for the Cure for Hepatitis C NOW! Read More »

Of the 1.1 million Americans living with HIV, only 25 percent are virally suppressed.

 Of the 1.1 million Americans living with HIV, only 25 percent are virally suppressed. This is worrisome data that reflects how the world’s biggest super power still has problems getting HIV infected people treated even with access to more than 24 HIV medications and federally funded programs https://www.thebody.com/content/69009/hiv-in-the-united-states-the-stages-of-care.html?ic=700100

Novel Cell and Gene Therapies for HIV

Although the development of cell-based and gene transfer therapies has been slow, progress in a number of areas is evident. Advances in the fields of gene-targeting strategies, T-cell-based approaches, and HSCs have been encouraging, and a series of ongoing and planned trials to establish proof of concept for strategies that could lead to successful cell …

Novel Cell and Gene Therapies for HIV Read More »

Scroll to Top